This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.
We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.
Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.
Resolved shortages
The following shortages have been resolved and supply has resumed to the Irish market:
| Product | Active Ingredient(s) |
| Bisolvon 4mg/5ml Oral Solution
PA23180/015/001
Opella Healthcare France SAS T/A Sanofi | Bromhexine |
| Naropin 7.5 mg/ml solution for injection
PA1691/026/002
Aspen Pharma Trading Limited | Ropivacaine |
| Lercanidipine Clonmel 10mg Film Coated Tablets
PA0126/187/001
Clonmel Healthcare Ltd | Lercanidipine |
| Temozolomide Clonmel 20 mg hard capsules
PA0126/188/002
Clonmel Healthcare Ltd | Temozolomide |
| Temozolomide Clonmel 140mg hard capsules
PA0126/188/004
Clonmel Healthcare Ltd | Temozolomide |
| Mestinon 60mg Tablets
PA2010/052/001
Mylan IRE Healthcare Limited | Pyridostigmine |
| Perdamel 2mg Film Coated Tablets
PA0126/169/004
Clonmel Healthcare Ltd | Risperidone |
| Amoxicillin 250mg/5ml Powder for Oral Suspension
PA0126/282/004 Clonmel Healthcare Ltd | Amoxicillin |
| Procoralan 7.5mg Film Coated Tablets
EU/1/05/316/8-14
Les Laboratoires Servier | Ivabradine |
| Fiasp 100 units/ml Solution for Injection
EU/1/16/1160/007
Novo Nordisk A/S | Insulin aspart |
| Moviprep Powder for Oral Solution
PA1336/001/001
Norgine B.V. | Macrogol 3350, sodium sulfate, sodium chloride, potassium chloride, ascorbic acid & sodium ascorbate |
| Tritace 2.5 mg Tablets
PA0540/084/006
Sanofi-Aventis Ireland Limited T/A SANOFI | Ramipril |
Newly notified shortages
The HPRA has been notified of a shortage of the following products:
| Product | Active Ingredient(s) |
| Norditropin FlexPro 10mg/1.5 ml, Solution for Injection
PA0218/040/012 Novo Nordisk A/S | Somatropin |
| Norditropin FlexPro 15mg/1.5 ml, Solution for Injection
PA0218/040/013
Novo Nordisk A/S | Somatropin |
| Gemcitabine Teva 40mg/ml Concentrate for Solution for Infusion
(5ml presentation)
PA1986/122/001
Teva B.V. | Gemcitabine |
| Clonactil 25mg Film Coated Tablets
PA0126/026/003
Clonmel Healthcare Ltd
| Chlorpromazine |
| Doxatan 4mg Tablets
PA0126/202/003
Clonmel Healthcare Ltd | Doxazosin |
| Doxatan XL 4mg Prolonged Release Tablets
PA0126/202/004
Clonmel Healthcare Ltd | Doxazosin |
| Temozolomide Teva 5mg Capsules
EU/1/09/606/001-002
Teva B.V. | Temozolomide |
| Atorvastatin Teva 10mg Film Coated Tablets
PA0749/110/001
Teva Pharma B.V. | Atorvastatin |
| Doxorubicin Teva 2 mg/ml Concentrate for Solution for Infusion
PA0749/083/001
Teva Pharma B.V. | Doxorubicin |
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.